IRVINE, Calif., April 18 (HSMN NewsFeed) -- Edwards Lifesciences Corporation (NYSE: EW ), the world leader in the science of heart valves, announced that yesterday the first patients were treated in a United States feasibility study using the Edwards SAP... Devices, CardiologyEdwards Lifesciences, SAPIEN, transcatheter heart valve (Source: HSMN NewsFeed)

 

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.



View the full article